Development code · Small Molecule
JNJ-922
JNJ-922 is a development code for Seltorexant (JNJ-42847922), developed by Johnson & Johnson.
- Status
- Phase 3 for Major depressive disorder
- Mechanism
- OX2R Antagonist
- Developer
- Johnson & Johnson
Programs
Also known as
- Seltorexant
- JNJ-42847922
- MIN-202
- 1293281-49-8